Mercator Medical EBIT per Share
The EBIT per Share of Mercator Medical (MRC.WA) as of Oct 16, 2026 is -1.55 PLN. In the previous year, EBIT per Share was 3.32 PLN — a change of -146.78% (lower).
Get this data via API
Financial Data API
EBIT per Share
-1.55PLN
YoY
-146.78%
Last updated:
The Mercator Medical EBIT per Share history
3 Years
10 Years
25 Years
Max
| YEAR | EBIT per Share | YoY |
|---|---|---|
| -1.55PLN | -146.78% | |
| 3.32PLN | -131.53% | |
| -10.54PLN | -43.19% | |
| -18.55PLN | -139.09% | |
| 47.45PLN | -52.86% | |
| 100.66PLN | +9,895.51% | |
| 1.01PLN | -25.59% | |
| 1.35PLN | +67.68% | |
| 0.81PLN | -50.98% | |
| 1.65PLN | -11.27% | |
| 1.86PLN | +22.31% | |
| 1.52PLN | +13.46% | |
| 1.34PLN | +1.48% | |
| 1.32PLN | -39.61% | |
| 2.18PLN | +71.43% | |
| 1.27PLN | — |
Access this data via the Eulerpool API
100,000 free requests/mo · no credit card
Mercator Medical Stock analysis
Frequently Asked Questions about Mercator Medical stock
EBIT per Share of Mercator Medical is -1.55 PLN in 2025.
EBIT per Share of Mercator Medical changed from 3.32 PLN to -1.55 PLN, representing a -146.78% change. The value is lower than the previous year.
On Eulerpool you can find the complete historical development of EBIT per Share Mercator Medical since 2006 – with annual values, charts, and detailed analysis.
EBIT per Share measures operating profit allocated to each outstanding share.
Access this data via the Eulerpool API
100,000 free requests/mo · no credit card
Income Statement — Mercator Medical
All Key Metrics — Mercator Medical
Valuation
Income Statement
Margins
Balance Sheet
- Total Assets
- Current Assets
- Cash & Equivalents
- Receivables
- Inventory
- Property, Plant & Equipment
- Goodwill
- Intangible Assets
- Equity
- Liabilities
- Debt
- Current Liabilities
- Long-term Debt
- Short-term Debt
- Retained Earnings
- Book Value per Share
- Tangible Book Value per Share
- Working Capital
- Investments
- Accounts Payable
- Non-Current Assets
- Short-Term Investments
- Long-Term Investments
- Net Debt
- Treasury Stock
- Minority Interest
- Deferred Tax Liabilities
- Net Tangible Assets
- Goodwill/Assets
- Intangibles/Assets
Cash Flow
- Operating Cash Flow
- Capital Expenditures
- Free Cash Flow
- FCF per Share
- Dividends Paid
- Share Buybacks
- Investing Cash Flow
- Financing Cash Flow
- CapEx / Revenue
- Cash Flow per Share
- Stock-Based Compensation
- Change in Working Capital
- Acquisitions (Net)
- Net Change in Cash
- CapEx/OCF
- FCF/Net Income
- FCF Conversion
- Cash Conversion
- Total Shareholder Payout
- CapEx/D&A
Profitability
- ROE
- ROA
- ROCE
- ROIC
- Asset Turnover
- Inventory Turnover
- Receivables Turnover
- Days Sales Outstanding
- Days Inventory Outstanding
- Days Payable Outstanding
- Cash Conversion Cycle
- CROIC
- Gross Profit/Assets
- Fixed Asset Turnover
- Equity Turnover
- Working Capital Turnover
- Payables Turnover
- Capital Intensity
- Receivables/Revenue
- Inventory/Revenue
- EBIT/Assets
Leverage
Growth
- Revenue Growth
- Revenue CAGR 3Y
- Revenue CAGR 5Y
- Revenue CAGR 10Y
- Earnings Growth
- EPS Growth
- EBIT Growth
- EBIT CAGR 3Y
- EBIT CAGR 5Y
- EBIT CAGR 10Y
- Dividend Growth
- FCF Growth
- Book Value Growth
- Earnings CAGR 3Y
- Earnings CAGR 5Y
- Earnings CAGR 10Y
- EPS CAGR 3Y
- EPS CAGR 5Y
- EBITDA Growth YoY
- EBITDA CAGR 3Y
- EBITDA CAGR 5Y
- Gross Profit Growth
- OCF Growth YoY
- Employee Growth
- Dividend CAGR 3Y
- Dividend CAGR 5Y
- Dividend CAGR 10Y
- Asset Growth
- Equity Growth
- Debt Growth
- CapEx Growth
- FCF CAGR 3Y
- FCF CAGR 5Y
- Market Cap Growth
- Share Count Growth